In October of 2007 the FDA granted approval of Evista for Breast Cancer Prevention. Evista has been on the market for about 10 years as an osteoporosis therapy. After its release, researchers noted that women on it were getting significantly less breast cancer. Several well-done studies confirmed the breast protective benefit of Evista, paving the way for the landmark FDA decision. This is a major advance in the fight for the cure. We now have a tool that works one step ahead of early detection…PREVENTION. After getting your bone density screening, please ask your physician about the details of Evista therapy for both osteoporosis and brest cancer prevention.